AbbVie
ABBV
#32
Rank
A$497.48 B
Marketcap
$281.52
Share price
0.26%
Change (1 day)
12.99%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.55

According to AbbVie's latest financial reports the company's current EPS (TTM) is $5.91. In 2022 the company made an earnings per share (EPS) of $10.69 an increase over its 2021 EPS that were of $10.42.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.55-48.15%
2022$10.692.63%
2021$10.42125.21%
2020$4.63-45.69%
2019$8.5248.35%
2018$5.747.6%
2017$5.34-9.3%
2016$5.8815.48%
2015$5.10185.53%
2014$1.78-57.11%
2013$4.16-21.69%
2012$5.3155.73%
2011$3.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.99-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.38 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.72 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.73 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.05 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.65 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.62-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.19-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.15-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA